Mispriced Risk of Infectious Diseases
By Dambisa Moyo
Global business leaders and investors are largely transfixed by two kinds of risk: macroeconomic and geopolitical. In the near term, this means a focus on the US Federal Reserve's impending rate hikes and the upcoming elections in France and Germany.
Over the longer term, it means awareness of structural risks like high sovereign debt, demographic shifts, and natural-resource scarcity. But there is a third, arguably more pernicious, risk lurking below most decision-makers' radar: infectious diseases.
According to the former director of the US Centres for Disease Control and Prevention, Tom Frieden, the world is at greater risk than ever from global health threats. People travel farther and more often. Supply chains, including for food and medicines, extend across the world. A poorly treated case of, say, tuberculosis (TB) in Asia or Africa can present in a hospital in the United States within days.
Against this background, scientists are concerned about the recent uptick in epidemics of diseases such as Zika, Ebola, and avian flu. And they are alarmed by the resurgence of life-threatening diseases such as influenza, HIV, malaria, and TB.
To be sure, in terms of fatalities, recent disease outbreaks and pandemics are a far cry from past global flu epidemics. Whereas the 2003 SARS epidemic resulted in 774 deaths, and the Ebola outbreak of 2014-2015 left 11,310 dead, the 1918-1920 flu epidemics claimed the lives of 100 million people – more than five times the number killed in the world war that had just ended.
Indeed, some 5 per cent of the world's population perished.
But the risks from infectious diseases that we face today could intensify substantially, owing to the rise of anti-microbial resistance (AMR). According to the World Health Organization, "480,000 people develop multi-drug resistant TB each year, and drug resistance is starting to complicate the fight against HIV and malaria, as well." Antibiotic resistance, the WHO cautions, is now present in every country, putting patients at risk of worse clinical outcomes and at greater risk of death, while increasing the burden on health systems.
England's Chief Medical Officer, Sally Davies, has warned that, if left unchecked, the growing impotence of drugs could be catastrophic. By 2050, she estimates, drug-resistant infections could be killing someone "every three seconds." The Review on AMR estimates that, at that point, some ten million lives could be lost each year, at a cumulative cost to global economic output of $100 trillion. To put that into perspective, world GDP today totals $74 trillion per year.
Yet the potential long-term human and economic consequences of AMR of are not widely appreciated by the public and, in particular, by financial markets. In fact, protection from public health threats is one vital area where markets do not deliver efficiently. As a result, it is governments that usually bear the costs of prevention and treatment.
With government budgets already overstretched, coping with the intensifying health burden from AMR will be difficult, to say the least. Yet governments are unlikely to move fast to mitigate this risk. On the contrary, experience indicates that governments often struggle to align public spending with underlying or mounting problems, such as public-health threats, until they reach a crisis point.
More people died of cancer in the US last year than in combat. In fact, last year's 580,000 cancer deaths exceed the roughly 430,000 battle deaths, on average, in World War I, World War II, the Korean War, the Vietnam War, and the Gulf War. Yet government spending on cancer averages approximately $4 billion per year. That is just over 0.5% of the annual military budget of roughly $718 billion.
Of course, government budget-allocation decisions are complicated and dogged by political imperatives. The US military employs some three million people, making it the single largest employer in the world, and there is substantial political pressure from some constituencies to place the highest priority on America's military dominance.
But it is not just a matter of how much is spent; it is also a matter of when. Governments don't wait for war to break out before investing in the military. Yet they do tend to wait for crises to erupt before they invest in fighting infectious diseases.
The world spent $15 billion on its emergency response to the SARS epidemic and $40 billion on its response to Ebola. In 1918, the crisis response to the flu pandemic cost some $17.5 trillion. Had countries spent more on mitigating the risk of such disease outbreaks – for example, by fortifying their health-care systems and promoting responsible use of antibiotics – those huge emergency payouts may not have been necessary. At the very least, they probably would have been smaller.
In this sense, the fight against infectious diseases closely resembles the fight against climate change. Though the threat is substantial, it is not immediate, so governments continue to pursue other priorities, allowing the threat to grow, largely out of sight. As a result, it is not adequately priced into the markets.
When the crisis finally erupts, the true scale of the threat will become clear. But by that point, it will be much more difficult and expensive to contain, resulting in far more casualties. Unfortunately, that point may be closer than anyone – government or investor – expects.
(Dambisa Moyo, an economist and author, sits on the board of directors of a number of global corporations. She is the author of Dead Aid, Winner Take All, and How the West Was Lost.)
- PEB to manage SOEs - Kabir 3422
- The other side of the story 3432
- First Ambassador of SL accredited to Principality of Andorra 3411
- Entrance test in Colombo on 21 May 3419
- A fair and expeditious solution 3419
- Anti-imperialist coalition now steadier than ever 3421
- Dramatic comeback for Europe 3433
- Turkish Thorn in EU’s side 3417
- Judges probing Bond scam threatened 3434
- Only 63.2% utilized – Ranil 3429
- UK officially exits from EU 3413
- Weerawansa admitted to Nat. Hospital 3414
- Monkey robs British student’s phone 3430
- Around 800,000 suffer from depression 3412
- Will meet when time is right 3416
- Freedom fighter or terrorist? 3208
- Fond memories 3189
- In pursuit of A dream 3186
- The farce and folly of the UNHRC 3244
- The deluge we caused in Geneva 3481
- Tragedy of the common class 3141
- I’ve got my day job back- Sharapova 2856
- CPCA conducts coaching programme 2844
- RTC ALL SET FOR A GALLOPING APRIL SEASON 2842
- Sinhawansa new General Secretary 2846
- Event successfully conducted on 18/19 March 2838
- Brazil book World Cup berth 2841
- Top-seed Wawrinka ousted 2837
- Aussie media slam 'classless' Kohli 2838
- Former England keeper Read to retire 2832
- South Africa 'saved by rain' 2831
- India’s Yogi Chief Minister 2533
- The roles people play Prioritizing Sex & Gender 3262
- Typical double standards & hypocrisy 3112
- Main cause of kidney diseases 3122
- ‘Posh Pooches’ to be lavished with love 3058
- Preventive measures 3035
- Opening a can of worms 3096
- COMPOUNDED MISERY 3591
- Forefathers of Tamils of SL were original inhabitants of this Country 3856
- Jaffna Prepares for Chronic Kidney Disease 3447
- North wanted to send 1,000 participants – Shantha Bandara 3085
- India should leave SL alone– Dr. Sudarshini Fernandopulle 3707
- International mechanism will try LTTE cadres again – Thulasi 3371
- Rewarded for sensitizing rights of the disabled 3256
- Foreign Judges can hear cases – Niran Anketell 3196
- We await President’s response – Gemunu 3252
- Jade Restaurants brings unbeatable seasonal offers 2609
- SRI LANKA’S FIRST TAXI METER WITH PRINTER INTRODUCED 2709
- Munchee treat for Sri Pada pilgrims 2606
- LAND ROVER DISCOVERY WITH DRONE TO HELP RED CROSS 2613
- Why Brexit is best for Britain 2612
- ‘BOC Triple Wasi’ produces 125 lucky winners 2612
- Avurudu discounts from retailers for 2620
- High rates and gifts for Avurudu from Pan Asia 2618
- DFCC Bank’s ‘Avurudu Hat-Trick’ offers season’s best rewards 2619
- Cinnamon TBCasia sets benchmark at ITB Berlin 2611
- Softlogic opens Burger King and Softlogic Max in Ja-Ela 2612
- Keells Super partners Institute of Post Harvest Technology 2619
- Singer Mega launches ‘Singer Mega Millionaire’ promotion 2613
- Global Housing & Real Estate commences Marriott project 2616
- London Stock Exchange-Deutsche Boerse deal blocked by EU 2619
- Domestic succumbs to burn injuries 2543
- The crisis in Parliament: Twilight of a functioning democracy 3524
- Mispriced Risk of Infectious Diseases 2460
- Musicalisation of Narrative 5193
- The Many Faces of Galle -Part 2 5232
- Footpaths Towards Deconstruction- Part 14 5202
- Afternoon Shadows 5209
- Living up to ideals 5379
- Clash of the Titans in Nuwara Eliya 5254
- Musicalized Version of Nostalgia 5476
- The Many Faces of Galle 6343
- The plight of our corals 1756
- India’s largest international décor mall launched in Bangalore 1735
- The games gods and politicians play 1726
- A challenged life 1721
- The Threshold: Patching up our privileged defeats 1791
- Animal assisted therapy 1719
- Empowering vocational studies 1835
- Your dream gaming machine 1843
- An enchanting remake 1841
- Refreshingly delicious 1836
- Xiumin 1845
- Batteries to firebombs 1354
Weather today 765